Navigation Links
Sinovac Releases Statement on Healive Vaccine Suspension
Date:12/2/2008

BEIJING, Dec. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Alternext US: SVA), a leading provider of vaccines in China, announced today that, the Health Services Bureau of Fengtai District in the City of Beijing suspended the use of 83 doses of inactivated hepatitis A vaccine Healive(R), following a report of the death of a minor in the Fengtai District on November 27, 2008, which coincided with the administration of the vaccine two days prior.

The suspended vaccine was part of lot 2008052105 that passed the routine government inspection in July 2008. To date, 19,850 doses vaccines from the lot have been distributed. According to data released by the Center for Adverse Drug Reaction Monitoring of Beijing, there is no other reported adverse reaction to the lot to date. Sinovac has not received, and is not aware of, similar notice of suspension from any other district in Beijing where the lot has been distributed or any other part of China where other lots of the Healive(R) vaccine have been distributed. On November 29, 2008, the Beijing Drug Administration and Drug Administration of Haidian District of City of Beijing conducted a joint administrative investigation that included an inspection of the company's manufacturing site and review of its manufacturing, inspection and sales processes, and concluded in a written report that no abnormality was found.

Sinovac has full confidence in the quality of its products. It will continue to cooperate with government agencies in their investigation of the incident and will provide an update once the investigation is completed.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sinovac Reports Third Quarter 2008 Unaudited Financial Results
2. Sinovac Named to Deloitte Technology Fast 50 China
3. Sinovac to Participate in Two Upcoming Investor Conferences
4. Sinovacs Credit Rating Upgraded to AAZ, Second Highest Rating
5. Sinovac Biotech Holds 2007 Annual General Meeting
6. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
7. Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
8. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
9. Sinovac Adjourns Annual General Meeting
10. Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference
11. Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... SAN JOSE, Calif. , May 17, 2013 ... an agreement has been reached with ... entire portfolio of anti-infective human monoclonal antibody (mAb) ... six anti-infective human mAb products for treatment of ... strains of Staphylococcus aureus , Pseudomonas ...
(Date:5/17/2013)... May 17, 2013 RURO Inc. ... version 4.1, a versatile refinement to the smart ... solution, improves its advanced methodical management for transgenic ... ezColony 4.1. The network-based platform provides user access ... research. While continuing to emphasize streamlined tasks, such ...
(Date:5/16/2013)... Athens, OH (PRWEB) May 16, 2013 ... freezer manufactured by Global Cooling, Inc., Athens, OH, USA, ... 8, 2013 by the International Society for Biological and ... Australia. The award, given to one product annually, recognizes ... energy efficient ultra-low temperature freezer. The award was ...
(Date:5/16/2013)... Vernon Hills, Ill. (PRWEB) May 16, 2013 ... including benchtop and portable models, from Cole-Parmer is ... professionals. The enhanced line includes: , The new ... that are true workhorses in the lab. They ... superior serum and plasma specimen separation. Their standard ...
Breaking Biology Technology:Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2Cole-Parmer Offers Enhanced Selection of Centrifuges 2
... Agreement Entered Into Between Genmab, and PDL ... ... COPENHAGEN, February 26 Genmab A/S (OMX: GEN),announced ... and,PDL BioPharma, Inc. under which Genmab would acquire PDL,s ...
... results mark 18th consecutive quarter of revenue growth ... 2007 Highlights: ... * Masimo SET pulse oximeter units increase 20% to 116,300 ... inventor of Pulse CO-Oximetry and Measure-Through,Motion & Low Perfusion pulse oximetry, today announced ...
... - a 45% ... increase Q4 2007 Diluted Net Income ... Q4 2007 New Bookings Increase to $39.2 ... provider of centralized ECG,eClinical technology, ePRO and other services to the pharmaceutical,biotechnology, medical device ...
Cached Biology Technology:Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance 2Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 2Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 4Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 5Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 6Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 7Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 8Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 9Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 10Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 11Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 12eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 2eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 3eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 4eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 5eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 6eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 7eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 8eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results 9
(Date:5/17/2013)... China---- Why Tibetan antelope can live at elevations ... collaborative research published in Nature Communications , ... provide evidence that some genetic factors may be ... environments. The data in this work will also ... the biology of other ruminant species. , The ...
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... Society (ENDO) 95th Annual Meeting in San Francisco, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... of male fallow deer provide rivals and potential mates with ... study, published in the open access journal BMC Biology ... change year by year and reflect changes in status and ... Mary, University of London together with Elisabetta Vannoni, University of ...
... (H5N1) outbreaks in Europe during the winter of 2005-2006 ... to researchers from Princeton University and the Erasmus Medical ... in the open-access journal PLoS Pathogens, show ... wild waterbirds away from areas of frozen water. ...
... 8, 2010) Autism Speaks, the world,s largest autism ... 16 new research grants totaling $5,223,743 over the next ... research, which provides the innovative discoveries that form the ... which further develops these discoveries in animal models, to ...
Cached Biology News:Honest deer every year 2Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 2Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 3Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 4Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 5Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 6Autism Speaks awards 16 new research grants funding more than $5 million over next 3 years 7
The Freeze 'N Squeeze DNA gel extraction kit uses a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. The kit includes materials for 100 preps....
The thermal printer, 120 V, is used to record fluorescence data acquired with the VersaFluor fluorometry systems. The printer includes a cable and power adaptor....
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
This thermal printer, 120 V, provides a permanent record of the preprogrammed method and run data for the PROTEAN IEF cell. Includes cable and power adaptor....
Biology Products: